Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000816074 | SCV000956564 | likely benign | Nemaline myopathy 2 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004028876 | SCV004979069 | uncertain significance | Inborn genetic diseases | 2024-02-28 | criteria provided, single submitter | clinical testing | The c.17330G>A (p.R5777H) alteration is located in exon 126 (coding exon 124) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 17330, causing the arginine (R) at amino acid position 5777 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000816074 | SCV002084034 | uncertain significance | Nemaline myopathy 2 | 2021-02-22 | no assertion criteria provided | clinical testing |